The MarketWatch News Department was not involved in the creation of this content. MONTREAL, March 15, 2024 /CNW/ - Pharmascience Canada is proud to announce the launch of pms- METHOTREXATE INJECTION ...
Sandoz and the FDA have notified healthcare professionals of a voluntary recall of Methotrexate Injection 50mg/2mL and 250mg/10mL vials that may contain small glass flakes. The flakes are the result ...
Methotrexate is a generic drug prescribed to treat certain types of cancers, arthritis, and psoriasis in adults and some children. As with other drugs, methotrexate can cause side effects, such as ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. WARNING: Important safety information is provided in a boxed warning ...
Data Support the Use of KRYSTEXXA® (pegloticase) Injection with Methotrexate to Treat Uncontrolled Gout in People With Mild-to-Moderate Chronic Kidney Disease -- MIRROR randomized controlled trial ...
“ Methotrexate is very familiar to rheumatologists, and it may allow more patients on KRYSTEXXA to continue over the treatment period.” Those who meet MIRROR (NCT03635957) eligibility criteria will ...
A 57-year-old woman with BRAF-positive metastatic melanoma presented to the dermatology clinic for evaluation of rapidly growing nodules on her face and warty growths over her trunk and extremities 3 ...
-- Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone -- -- Trial data ...
German drug maker Sandoz on Thursday announced a recall of two sizes of methotrexate injection vials sold under the Sandoz and Parenta brands because of the possible presence of glass flakes. “While ...
TOKYO, Sept 26, 2022 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have obtained ...
Methotrexate 300 mg/m 2 by iv. infusion over 12 h Day 2 Etoposide 100 mg/m 2 by iv. infusion over 30 min Actinomycin D 0.5 mg iv. bolus Folinic acid rescue 15 mg orally every 12 h for four doses ...
SAN DIEGO, CA—Golimumab plus methotrexate maintains improvements in signs and symptoms of rheumatoid arthritis and physical function and inhibits structural damage progression long-term, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback